remacemide has been researched along with Complex Partial Epilepsy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, P; Harrison, B; Mawer, G; Richens, A | 1 |
| Chadwick, D; Crawford, P; Harrison, B; Smith, D | 1 |
2 trial(s) available for remacemide and Complex Partial Epilepsy
| Article | Year |
|---|---|
A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Epilepsy, Complex Partial; Epilepsy, Generalized; Female; Humans; Male; Middle Aged; Treatment Outcome | 2000 |
Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy.
Topics: Acetamides; Adult; Anticonvulsants; Biotransformation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Epilepsy, Complex Partial; Epilepsy, Generalized; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Treatment Outcome | 2000 |